Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZTS Zoetis Inc.

未开盘 03-25 16:00:00 EDT

116.71

+0.78

+0.67%

盘后116.02

-0.69-0.59%

19:44 EDT

最高118.14	最低115.30	成交量307.89万
今开117.26	昨收115.93	日振幅2.45%
总市值492.67亿	流通市值492.52亿	总股本4.22亿
成交额3.59亿	换手率0.73%	流通股本4.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZTS","market":"US","secType":"STK","nameCN":"Zoetis Inc.","latestPrice":116.71,"timestamp":1774468800000,"preClose":115.93,"halted":0,"volume":3078905,"hourTrading":{"tag":"盘后","latestPrice":116.02,"preClose":116.71,"latestTime":"19:44 EDT","volume":85225,"amount":9946256.83,"timestamp":1774482290621,"change":-0.69,"changeRate":-0.005912,"amplitude":0.005912},"delay":0,"changeRate":0.0067281980505476315,"floatShares":422000000,"shares":422127709,"eps":6.02,"marketStatus":"未开盘","change":0.78,"latestTime":"03-25 16:00:00 EDT","open":117.26,"high":118.14,"low":115.3,"amount":358776024.77075005,"amplitude":0.024498,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.02,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774512000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1359694800000,"exchange":"NYSE","adjPreClose":115.93,"dividendRate":0.017394,"preHourTrading":{"tag":"盘前","latestPrice":117.4245,"preClose":115.93,"latestTime":"09:25 EDT","volume":335593,"amount":38906101.9132,"timestamp":1774445142412,"change":1.4945,"changeRate":0.012891,"amplitude":0.017856},"postHourTrading":{"tag":"盘后","latestPrice":116.02,"preClose":116.71,"latestTime":"19:44 EDT","volume":85225,"amount":9946256.83,"timestamp":1774482290621,"change":-0.69,"changeRate":-0.005912,"amplitude":0.005912},"volumeRatio":0.500952,"impliedVol":0.3582,"impliedVolPercentile":0.792},"requestUrl":"/m/hq/s/ZTS","defaultTab":"news","newsList":[{"id":"1162582301","title":"硕腾公司收购Neogen®动物基因组学业务，加速精准动物健康创新","url":"https://stock-news.laohu8.com/highlight/detail?id=1162582301","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162582301?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:11","pubTimestamp":1772453469,"startTime":"0","endTime":"0","summary":"硕腾公司宣布将收购Neogen®的动物基因组学业务，此举将显著推动其在精准动物健康领域的创新进程。此次收购标志着硕腾在动物保健解决方案方面的战略布局进一步深化，旨在通过基因组学技术提升动物健康管理的精确性和效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0385154629.USD","NEOG","LU1721429402.USD","LU0471298777.SGD","BK4534","LU1721429741.USD","LU1941712264.USD","LU1236620834.HKD","LU2111349929.HKD","LU2360106947.USD","LU2308191902.HKD","LU0345774631.USD","LU2271345857.HKD","LU0107464264.USD","LU2089284900.SGD","LU0158827781.USD","IE00B19Z9505.USD","LU1941712348.USD","LU0079474960.USD","LU2028103732.USD","LU0471298694.HKD","LU2211817866.USD","BK4585","BK4588","LU2089283258.USD","ZTS","LU2023251221.USD","LU0158827948.USD","LU0345774391.USD","LU1236620750.USD","LU0289739699.SGD","BK4198","LU0058720904.USD","BK4007"],"gpt_icon":0},{"id":"1133797891","title":"异动解读 | Zoetis季度业绩及展望超预期，盘前大涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133797891","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133797891?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:37","pubTimestamp":1770899834,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis Inc. (ZTS) 今日盘前股价大幅上涨6.12%，表现强劲。消息面上，该公司公布的第四季度业绩及2026年财务指引均超出市场预期。具体来看，Zoetis第四季度调整后每股利润为1.48美元，高于市场预期的1.40美元。同时，公司预计2026年调整后每股收益将在7.00美元至7.10美元之间，其中间值高于分析师普遍预期的6.80美元；预计2026年营收将在98.25亿美元至100.25亿美元之间，其中间值也高于市场预期的99.14亿美元。这些乐观的业绩数据和未来展望显著提振了投资者信心，成为推动股价在盘前交易时段大幅走高的主要原因。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"gpt_icon":0},{"id":"1124112870","title":"财报前瞻｜Zoetis Inc.本季度营收预计增2.61%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1124112870","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124112870?lang=zh_cn&edition=full","pubTime":"2026-02-05 10:14","pubTimestamp":1770257650,"startTime":"0","endTime":"0","summary":"Zoetis Inc.将于2026年02月12日发布最新季度财报，市场预期其营收与每股收益将温和增长，盈利质量与费用节奏成为关注焦点。从近期机构研报与观点追踪看，市场对Zoetis Inc.的看法偏多，占比较高的一方认为本季度将延续稳健增长轨迹。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Zoetis Inc.本季度营收预计增2.61%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"gpt_icon":0},{"id":"2606755165","title":"别只盯着黄金白银！分析师：这一商品板块正在积累动能","url":"https://stock-news.laohu8.com/highlight/detail?id=2606755165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606755165?lang=zh_cn&edition=full","pubTime":"2026-01-28 07:27","pubTimestamp":1769556434,"startTime":"0","endTime":"0","summary":"在黄金、白银等硬商品行情持续吸引市场目光之际，软商品板块正悄悄积累动能，逐步走进“舞台”中央。化肥与基础材料板块方面，$CF工业$控股年初至今涨幅已超过18%，并录得四周连涨，为去年以来最长连胜周期。相较之下，同业$美国美盛$年内表现基本持平，凸显CF的相对强势。防御型食品板块方面，$美国达尔令国际$过去三个月累计上涨约23%，五周连涨，周线50周均线多年后首次拐头向上。","market":"us","thumbnail":"https://static.tigerbbs.com/8466d39a9e33250f4b2bce0eef42d3d7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8466d39a9e33250f4b2bce0eef42d3d7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2fa34c06b40980242a48e390e7e61d16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398257.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["DAR","ELAN","BK4588","ADM","NTR","MOO","BG","DE","CF","BK4585","MOS","ZTS"],"gpt_icon":1},{"id":"1194652354","title":"Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据，到期日为2029年","url":"https://stock-news.laohu8.com/highlight/detail?id=1194652354","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194652354?lang=zh_cn&edition=full","pubTime":"2025-12-16 14:20","pubTimestamp":1765866012,"startTime":"0","endTime":"0","summary":"Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据，到期日为2029年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS","LU0158827781.USD","LU1941712264.USD","BK4585","LU1941712348.USD","LU0345774391.USD","LU1721429741.USD","LU2111349929.HKD","LU2089284900.SGD","LU2028103732.USD","IE00B19Z9505.USD","LU0471298777.SGD","BK4007","LU0107464264.USD","LU2023251221.USD","LU0289739699.SGD","LU2271345857.HKD","LU1721429402.USD","LU2360106947.USD","BK4588","LU0345774631.USD","LU2089283258.USD","LU0079474960.USD","BK4534","LU0158827948.USD","LU0385154629.USD","LU0058720904.USD","LU2308191902.HKD","LU0471298694.HKD"],"gpt_icon":0},{"id":"1199092124","title":"Zoetis获得加拿大卫生部批准，Portela™（Relfovetmab注射液）可缓解猫咪的骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1199092124","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199092124?lang=zh_cn&edition=full","pubTime":"2025-12-05 21:30","pubTimestamp":1764941417,"startTime":"0","endTime":"0","summary":"Zoetis获得加拿大卫生部的批准，Portela™（Relfovetmab注射液）可用于缓解猫咪骨关节炎所致的疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0158827781.USD","LU0471298694.HKD","LU0158827948.USD","BK4585","LU2308191902.HKD","LU2089283258.USD","LU2023251221.USD","LU0345774391.USD","LU0289739699.SGD","LU2271345857.HKD","BK4007","LU2111349929.HKD","LU1721429402.USD","LU1941712264.USD","LU2028103732.USD","ZTS","BK4588","BK4534","LU0079474960.USD","LU0471298777.SGD","LU0058720904.USD","LU0385154629.USD","LU0107464264.USD","LU2089284900.SGD","LU0345774631.USD","IE00B19Z9505.USD","LU1941712348.USD","LU2360106947.USD","LU1721429741.USD"],"gpt_icon":0},{"id":"1137813317","title":"Zoetis获得欧洲委员会对Lenivia®（Izenivetmab）的市场许可，以减轻犬类骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1137813317","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137813317?lang=zh_cn&edition=full","pubTime":"2025-11-27 05:16","pubTimestamp":1764191777,"startTime":"0","endTime":"0","summary":"Zoetis获得欧洲委员会对Lenivia®（Izenivetmab）的市场许可，以减轻犬类骨关节炎相关疼痛","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS","LU0158827781.USD","LU1941712264.USD","BK4585","LU1941712348.USD","LU0345774391.USD","LU2111349929.HKD","LU2089284900.SGD","LU2028103732.USD","IE00B19Z9505.USD","LU0471298777.SGD","BK4007","LU0107464264.USD","LU2023251221.USD","LU0289739699.SGD","LU2271345857.HKD","LU2360106947.USD","BK4588","LU0345774631.USD","LU2089283258.USD","LU0079474960.USD","BK4534","LU0158827948.USD","LU0385154629.USD","LU0058720904.USD","LU2308191902.HKD","LU0471298694.HKD"],"gpt_icon":0},{"id":"1187876037","title":"异动解读 | Zoetis盘前大跌9.17%，下调年度收入预期且季度业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1187876037","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187876037?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:40","pubTimestamp":1762260026,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis Inc.今日盘前股价大跌9.17%，引发市场关注。该公司股价在盘前交易中跌至133美元左右，较前一交易日收盘价大幅下挫。Zoetis将全年收入预测区间调整为94.0亿美元至94.8亿美元，低于此前预测的94.5亿美元至96.0亿美元。此外，Zoetis公布的第三季度业绩也未能完全达到市场预期。值得注意的是，截至上一交易日收盘，Zoetis股价已累计下跌约11%，显示出投资者对公司近期表现的持续担忧。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"gpt_icon":0},{"id":"1186621787","title":"Zoetis宣布Rob Polzer于2025年底退休，并任命Kevin Esch为2026年起全球动物健康领军企业的研发总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1186621787","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186621787?lang=zh_cn&edition=full","pubTime":"2025-11-04 05:16","pubTimestamp":1762204575,"startTime":"0","endTime":"0","summary":"Zoetis宣布Rob Polzer将于2025年底退休，同时任命Kevin Esch为2026年起全球动物健康领域的研究与开发总裁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","BK4007","BK4534","LU0345774631.USD","LU2089283258.USD","LU2028103732.USD","LU0058720904.USD","BK4585","LU0385154629.USD","LU1941712264.USD","LU2308191902.HKD","LU2089284900.SGD","LU0345774391.USD","LU0289739699.SGD","ZTS","LU2023251221.USD","LU0471298777.SGD","LU0158827948.USD","IE00B19Z9505.USD","LU0471298694.HKD","LU0158827781.USD","LU1941712348.USD","LU2111349929.HKD","BK4588","LU0107464264.USD","LU2271345857.HKD","LU2360106947.USD"],"gpt_icon":0},{"id":"1156037245","title":"Zoetis获欧洲委员会批准Portela®（Relfovetmab）用于缓解猫患骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1156037245","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156037245?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:23","pubTimestamp":1761744225,"startTime":"0","endTime":"0","summary":"Zoetis Inc.：*Zoetis获欧洲委员会批准Portela®（Relfovetmab）用于缓解猫患骨关节炎相关疼痛* Zoetis Inc. - 预计Portela将在2026年在欧盟上市  ((路透社投资简报; email: reutersinvestor.briefs@thomsonreuters.com))  来源日期/时间 = 29-OCT-2025 12:30:00.16 GMT","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089284900.SGD","LU0385154629.USD","LU1941712264.USD","BK4534","LU2023251221.USD","LU0158827948.USD","LU0158827781.USD","LU2028103732.USD","LU0345774391.USD","BK4007","LU0107464264.USD","BK4588","LU0058720904.USD","LU2089283258.USD","LU2111349929.HKD","LU0345774631.USD","ZTS","LU0289739699.SGD","LU2360106947.USD","LU0079474960.USD","BK4585","IE00B19Z9505.USD","LU1941712348.USD","LU2271345857.HKD","LU2308191902.HKD","LU0471298694.HKD","LU0471298777.SGD"],"gpt_icon":0},{"id":"1143607798","title":"Zoetis获得欧洲委员会对Portela®（Relfovetmab）的市场营销授权以缓解猫咪与骨关节炎相关的疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1143607798","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143607798?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:30","pubTimestamp":1761741033,"startTime":"0","endTime":"0","summary":"Zoetis获得欧洲委员会对Portela®（Relfovetmab）的市场营销授权，以缓解猫咪与骨关节炎相关的疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2111349929.HKD","LU2308191902.HKD","LU0385154629.USD","LU2023251221.USD","LU2089284900.SGD","LU0289739699.SGD","ZTS","LU2089283258.USD","LU2360106947.USD","LU0058720904.USD","LU1941712348.USD","LU0471298694.HKD","LU1941712264.USD","LU0079474960.USD","LU0345774631.USD","LU0345774391.USD","BK4588","LU2028103732.USD","IE00B19Z9505.USD","LU0158827781.USD","LU0107464264.USD","BK4534","BK4007","BK4585","LU0158827948.USD","LU0471298777.SGD","LU2271345857.HKD"],"gpt_icon":0},{"id":"1107496021","title":"Zoetis发布加拿大健康部门对Lenivia®（Izenivetmab注射液）用于缓解犬只骨关节炎（Oa）疼痛的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1107496021","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107496021?lang=zh_cn&edition=full","pubTime":"2025-10-15 19:01","pubTimestamp":1760526077,"startTime":"0","endTime":"0","summary":"Zoetis发布加拿大健康部门对Lenivia®（Izenivetmab注射液）用于缓解犬只骨关节炎（Oa）疼痛的批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023251221.USD","LU0158827948.USD","LU2028103732.USD","LU0345774391.USD","LU0107464264.USD","LU1941712348.USD","LU2089284900.SGD","ZTS","LU1941712264.USD","LU0289739699.SGD","BK4588","BK4585","LU2271345857.HKD","LU0345774631.USD","LU2089283258.USD","LU0079474960.USD","BK4534","LU2360106947.USD","LU2111349929.HKD","LU2308191902.HKD","IE00B19Z9505.USD","LU0058720904.USD","LU0158827781.USD","LU0471298694.HKD","LU0385154629.USD","LU0471298777.SGD","BK4007"],"gpt_icon":0},{"id":"1115730463","title":"Zoetis Inc.获得兽药产品委员会对Lenivia®(Izenivetmab)的积极意见，用于缓解犬类骨关节炎疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1115730463","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115730463?lang=zh_cn&edition=full","pubTime":"2025-10-11 04:16","pubTimestamp":1760127402,"startTime":"0","endTime":"0","summary":"Zoetis Inc.获得兽药产品委员会对Lenivia®(Izenivetmab)的积极意见，该药物用于缓解犬类骨关节炎疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2111349929.HKD","LU1941712348.USD","LU0158827781.USD","LU0079474960.USD","BK4588","LU2028103732.USD","LU0345774391.USD","LU2089283258.USD","IE00B19Z9505.USD","ZTS","BK4534","LU1941712264.USD","LU0345774631.USD","LU0385154629.USD","LU0289739699.SGD","LU2360106947.USD","BK4007","BK4585","LU0471298694.HKD","LU2308191902.HKD","LU0158827948.USD","LU0107464264.USD","LU0058720904.USD","LU0471298777.SGD","LU2023251221.USD","LU2271345857.HKD","LU2089284900.SGD"],"gpt_icon":0},{"id":"1162793149","title":"Zoetis获得Dectomax®-CA1注射剂条件性批准，用于预防和治疗牛新世界螺旋蝇蛆病","url":"https://stock-news.laohu8.com/highlight/detail?id=1162793149","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162793149?lang=zh_cn&edition=full","pubTime":"2025-10-01 04:16","pubTimestamp":1759263414,"startTime":"0","endTime":"0","summary":"Zoetis获得了其Dectomax®-CA1注射剂的条件性批准，该产品专门用于预防和治疗牛的新世界螺旋蝇蛆病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","BK4007","BK4534","LU0345774631.USD","LU2089283258.USD","LU2028103732.USD","LU0058720904.USD","BK4585","LU0385154629.USD","LU1941712264.USD","LU2308191902.HKD","LU2089284900.SGD","LU0345774391.USD","LU0289739699.SGD","ZTS","LU2023251221.USD","LU0471298777.SGD","LU0158827948.USD","IE00B19Z9505.USD","LU0471298694.HKD","LU0158827781.USD","LU1941712348.USD","LU2111349929.HKD","BK4588","LU0107464264.USD","LU2271345857.HKD","LU2360106947.USD"],"gpt_icon":0},{"id":"1178037747","title":"美国卫生与公众服务部：FDA有条件批准Dectomax-CA1注射液用于预防和治疗牛类新世界螺旋蝇蛆感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1178037747","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178037747?lang=zh_cn&edition=full","pubTime":"2025-10-01 02:38","pubTimestamp":1759257500,"startTime":"0","endTime":"0","summary":"美国卫生与公众服务部宣布，美国食品药品监督管理局已有条件批准Dectomax-CA1注射液，该药物用于预防和治疗牛类新世界螺旋蝇蛆感染。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0079474960.USD","LU2111349929.HKD","LU0471298694.HKD","LU2308191902.HKD","LU0107464264.USD","ZTS","BK4007","LU0385154629.USD","BK4585","LU1941712348.USD","LU0471298777.SGD","LU2023251221.USD","LU0289739699.SGD","LU1941712264.USD","LU2360106947.USD","LU0058720904.USD","BK4588","LU0158827781.USD","LU0158827948.USD","LU2271345857.HKD","LU0345774391.USD","LU2089283258.USD","LU0345774631.USD","IE00B19Z9505.USD","LU2028103732.USD","LU2089284900.SGD"],"gpt_icon":0},{"id":"2512046953","title":"硕腾2024财年实现净利润24.86亿美元，同比增加6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512046953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512046953?lang=zh_cn&edition=full","pubTime":"2025-02-17 00:01","pubTimestamp":1739721669,"startTime":"0","endTime":"0","summary":"2月17日，硕腾公布财报，公告显示公司2024财年净利润为24.86亿美元，同比增加6.06%；其中营业收入为92.56亿美元，同比增加8.33%，每股基本收益为5.47美元。从资产负债表来看，硕腾总负债94.67亿美元，其中短期债务14.01亿美元，资产负债比为1.51，流动比率为1.76。机构评级：截至2025年2月17日，当前有15家机构对硕腾目标价做出预测，其中目标均价为214.47美元，其中最低目标价为180.00美元，最高目标价为244.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"gpt_icon":0},{"id":"2512596924","title":"动保巨头年报公布！硕腾2024年盈利约198亿元，默沙东动保营收约430亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512596924","media":"新牧网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512596924?lang=zh_cn&edition=full","pubTime":"2025-02-16 18:43","pubTimestamp":1739702626,"startTime":"0","endTime":"0","summary":"另外，近日默沙东公布2024年财报，2024年默沙东总营收641.68亿美元，同比增长7%；2024年来自动物保健部门的营收为59亿美元，同比增长4%。2024 年第四季度净利润为5.81亿美元，摊薄每股收益为1.29美元，分别较报告期增长11%和13%。2024全年净利润为25亿美元，摊薄每股收益为5.47美元，分别较报告基础增长6%和8%。2024年，默沙东总营收641.68亿美元，同比增长7%。展望2025年，默沙东预计全球销售额将在641亿美元至656亿美元之间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","ZTS"],"gpt_icon":0},{"id":"2511571617","title":"硕腾盘中异动 临近收盘快速跳水5.02%报156.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511571617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511571617?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:50","pubTimestamp":1739566218,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时50分，硕腾股票出现波动，股价急速跳水5.02%。截至发稿，该股报156.65美元/股，成交量641.473万股，换手率1.43%，振幅4.74%。最近的财报数据显示，该股实现营业收入92.56亿美元，净利润24.86亿美元，每股收益5.47美元，毛利63.96亿美元，市盈率28.67倍。硕腾股票所在的制药行业中，整体跌幅为1.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021504501996236d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021504501996236d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2111349929.HKD","LU0058720904.USD","LU0345774631.USD","LU2360106947.USD","LU0385154629.USD","IE00B19Z9505.USD","BK4007","LU0158827781.USD","LU0471298777.SGD","LU2089284900.SGD","BK4585","LU0471298694.HKD","LU2023251221.USD","LU1941712264.USD","PTPI","ZTS","LU2089283258.USD","LU1941712348.USD","LU2028103732.USD","LU0158827948.USD","LU0345774391.USD","LU0079474960.USD","BK4534","LU2308191902.HKD","BK4588","LU0289739699.SGD","LU2271345857.HKD"],"gpt_icon":0},{"id":"2511692036","title":"巴克莱：维持Zoetis(ZTS.US)评级，由增持调整至增持评级, 目标价由242.00美元调整至244.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692036","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511692036?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:13","pubTimestamp":1739549632,"startTime":"0","endTime":"0","summary":"巴克莱：维持Zoetis(ZTS.US)评级，由增持调整至增持评级, 目标价由242.00美元调整至244.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15001348179109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ZTS"],"gpt_icon":0},{"id":"2511693259","title":"硕腾发布2024年财报：宠物板块营收大增13%，中国市场迎来转折","url":"https://stock-news.laohu8.com/highlight/detail?id=2511693259","media":"宠物行业白皮书","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511693259?lang=zh_cn&edition=full","pubTime":"2025-02-14 18:30","pubTimestamp":1739529054,"startTime":"0","endTime":"0","summary":"白皮书团队讯，2月13日，硕腾正式发布了其2024年财报：全年营收93亿美元，同比增长8%，净利润25亿美元；第四季度营收23亿美元，同比增长5%，净利润5.81亿美元。这一变化也表现在了业绩上，实际上，自2023Q1季度开始，硕腾在国内市场的营收已经连续7个季度同比下滑了。但受前三季度业绩拖累，2024年全年，硕腾中国市场累计营收2.70亿美元，同比下降约16%。附：硕腾2024年业绩演示报告End《2025年中国宠物行业白皮书》正式发布行业资料包","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214215135abcefc81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214215135abcefc81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS","YINN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zoetis.com","stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":-0.0722},{"period":"3month","weight":-0.07},{"period":"6month","weight":-0.1867},{"period":"1year","weight":-0.2764},{"period":"ytd","weight":-0.0724}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕腾公司于2012年7月在美国特拉华州成立。硕腾是动物保健行业的全球领先企业，专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":-0.014971},{"month":2,"riseRate":0.615385,"avgChangeRate":0.01803},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.020436},{"month":4,"riseRate":0.538462,"avgChangeRate":0.015522},{"month":5,"riseRate":0.692308,"avgChangeRate":0.026998},{"month":6,"riseRate":0.692308,"avgChangeRate":0.013528},{"month":7,"riseRate":0.846154,"avgChangeRate":0.031992},{"month":8,"riseRate":0.769231,"avgChangeRate":0.012395},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.007561},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.008448},{"month":11,"riseRate":0.692308,"avgChangeRate":0.038835},{"month":12,"riseRate":0.538462,"avgChangeRate":0.016303}],"exchange":"NYSE","name":"Zoetis Inc.","nameEN":"Zoetis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zoetis Inc.,ZTS,Zoetis Inc.股票,Zoetis Inc.股票老虎,Zoetis Inc.股票老虎国际,Zoetis Inc.行情,Zoetis Inc.股票行情,Zoetis Inc.股价,Zoetis Inc.股市,Zoetis Inc.股票价格,Zoetis Inc.股票交易,Zoetis Inc.股票购买,Zoetis Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}